Piper Sandler Raises Perrigo (NYSE:PRGO) Price Target to $39.00

Perrigo logo with Medical background

Perrigo (NYSE:PRGO - Free Report) had its price target upped by Piper Sandler from $35.00 to $39.00 in a report published on Monday, Benzinga reports. The firm currently has an overweight rating on the stock.

Other research analysts also recently issued reports about the company. JPMorgan Chase & Co. cut their price objective on Perrigo from $48.00 to $41.00 and set an overweight rating for the company in a research report on Wednesday, February 28th. StockNews.com raised shares of Perrigo from a hold rating to a buy rating in a research note on Wednesday, April 3rd.

Read Our Latest Stock Report on PRGO

Perrigo Stock Up 1.1 %

NYSE:PRGO traded up $0.35 during trading hours on Monday, hitting $31.75. The company's stock had a trading volume of 1,330,374 shares, compared to its average volume of 1,955,853. The stock has a fifty day moving average of $30.88 and a 200-day moving average of $30.83. The stock has a market capitalization of $4.30 billion, a P/E ratio of -317.50 and a beta of 0.64. Perrigo has a 52-week low of $25.77 and a 52-week high of $40.28. The company has a current ratio of 1.79, a quick ratio of 1.07 and a debt-to-equity ratio of 0.76.


Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.03. Perrigo had a negative net margin of 0.27% and a positive return on equity of 7.34%. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period last year, the firm earned $0.75 EPS. The company's revenue for the quarter was up .1% on a year-over-year basis. On average, equities analysts forecast that Perrigo will post 2.55 earnings per share for the current year.

Perrigo Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a dividend of $0.276 per share. The ex-dividend date was Thursday, March 7th. This is a boost from Perrigo's previous quarterly dividend of $0.27. This represents a $1.10 annualized dividend and a dividend yield of 3.48%. Perrigo's payout ratio is currently -1,100.00%.

Insider Activity at Perrigo

In other news, EVP Alison Ives acquired 2,490 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were purchased at an average price of $27.26 per share, for a total transaction of $67,877.40. Following the acquisition, the executive vice president now directly owns 16,122 shares of the company's stock, valued at approximately $439,485.72. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Robert Willis bought 6,000 shares of the firm's stock in a transaction on Thursday, February 29th. The stock was purchased at an average price of $25.87 per share, for a total transaction of $155,220.00. Following the transaction, the executive vice president now owns 25,105 shares in the company, valued at $649,466.35. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Alison Ives bought 2,490 shares of the firm's stock in a transaction on Tuesday, March 5th. The stock was purchased at an average price of $27.26 per share, with a total value of $67,877.40. Following the transaction, the executive vice president now owns 16,122 shares in the company, valued at approximately $439,485.72. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 17,990 shares of company stock worth $475,227. 0.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of PRGO. GAMMA Investing LLC bought a new position in shares of Perrigo in the fourth quarter valued at approximately $30,000. Dark Forest Capital Management LP acquired a new stake in Perrigo during the first quarter valued at approximately $31,000. Parkside Financial Bank & Trust lifted its stake in Perrigo by 1,694.8% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,041 shares of the company's stock valued at $34,000 after purchasing an additional 983 shares during the last quarter. Hexagon Capital Partners LLC acquired a new stake in Perrigo during the fourth quarter valued at approximately $37,000. Finally, Ronald Blue Trust Inc. lifted its stake in Perrigo by 132.3% during the third quarter. Ronald Blue Trust Inc. now owns 1,157 shares of the company's stock valued at $39,000 after purchasing an additional 659 shares during the last quarter. Institutional investors own 95.91% of the company's stock.

Perrigo Company Profile

(Get Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Featured Stories

Should you invest $1,000 in Perrigo right now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: